Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ADAPY and buy or sell other stocks, ETFs, and their options commission-free!

About ADAPY

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Christopher James Hill
CEOChristopher James Hill
Employees
506
Employees506
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2014
Founded2014
Employees
506
Employees506

ADAPY Key Statistics

Market cap
7.42M
Market cap7.42M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
938.55K
Average volume938.55K
High today
$0.03
High today$0.03
Low today
$0.028
Low today$0.028
Open price
$0.03
Open price$0.03
Volume
386.72K
Volume386.72K
52 Week high
$0.6214
52 Week high$0.6214
52 Week low
$0.001
52 Week low$0.001

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.